Product NDC: | 0310-0209 |
Proprietary Name: | ZOMIG ZMT |
Non Proprietary Name: | Zolmitriptan |
Active Ingredient(s): | 2.5 mg/1 & nbsp; Zolmitriptan |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, ORALLY DISINTEGRATING |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0310-0209 |
Labeler Name: | AstraZeneca Pharmaceuticals LP |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021231 |
Marketing Category: | NDA |
Start Marketing Date: | 20010402 |
Package NDC: | 0310-0209-20 |
Package Description: | 6 BLISTER PACK in 1 CARTON (0310-0209-20) > 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
NDC Code | 0310-0209-20 |
Proprietary Name | ZOMIG ZMT |
Package Description | 6 BLISTER PACK in 1 CARTON (0310-0209-20) > 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
Product NDC | 0310-0209 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Zolmitriptan |
Dosage Form Name | TABLET, ORALLY DISINTEGRATING |
Route Name | ORAL |
Start Marketing Date | 20010402 |
Marketing Category Name | NDA |
Labeler Name | AstraZeneca Pharmaceuticals LP |
Substance Name | ZOLMITRIPTAN |
Strength Number | 2.5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Serotonin 1b Receptor Agonists [MoA],Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] |